Association between pronounced IgA response in RSV bronchiolitis and development of allergic sensitization

Pediatric Allergy and Immunology

Volumn 8, Issue 1, 1997, Pages 1-6

  Strannegard O ^a   Cello, J ^a   Bjarnason, R ^b   Sigurbergsson, F ^b   Sigurs, N ^b  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b BORÅS HOSPITAL   (Sweden)

Author keywords

Atopy; Bronchiolitis; IgA response; RRV

Indexed keywords

IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN E ANTIBODY; IMMUNOGLOBULIN G ANTIBODY;

ALLERGIC ASTHMA; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; BRONCHIOLITIS; CHILD; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; ETIOLOGY; FEMALE; HELPER CELL; HUMAN; INFANT; MALE; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY TRACT INFECTION; SENSITIZATION; SEROEPIDEMIOLOGY;

EID: 0030872997     PISSN: 09056157     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-3038.1997.tb00134.x     Document Type: Article

References (30)

1. SIGURS N, BJARNASON R, SIGURBERGSSON F, KJELLMAN B, BJORKSTÉN B. Asthma and immunoglobulin E antibodies after respiratory syncytial virus bronchiolitis: a prospective cohort study with matched controls. Pediatrics 1995: 95: 500-5.
2. WELLIVER RC. RSV and chronic asthma. Lancet 1995: 34: 789-90.
3. WELLIVER RC, KAUL TN, OGRA PL. The appearance of cell-bound IgE in respiratory tract epithelium after respiratory syncytial virus infection. N Engl J Med 1980: 303: 1198-202.
4. WELLIVER RC, KAUL TN, SUN M, OGRA PL. Defective regulation of immune responses in respiratory syncytial virus infection. J Immunol 1984: 133: 1925-30.
5. WELLIVER RC, WONG DT, SUN M, MIDDLETON E, VAUGHN RS, OGRA PL. The development of respiratory syncytial virus-specific IgE and the release of histamine in nasopharyngeal secretions after infection. N Engl J Med 1981: 305: 841-6.
6. FRICK OL, BROOKS DL. Immunoglobin E antibodies to pollens augmented in dogs by virus vaccines. Am J Vet Res 1983: 44: 440-5.
7. GRAHAM BS, HENDERSON GS, TANG YW, LU X, NEUZIL KM, COLLEY DG. Priming immunization determines T helper cytokine mRNA expression patterns in lungs of mice challenged with respiratory syncytial virus. J Immunol 1993: 151: 2032-40.
8. ALWAN WH, KOZLOWSKA W, OPENSHAW PJ. Distinct types of lung disease caused by functional subsets of anti-viral T cells. J Exp Med 1994: 179: 81-7.
9. OPENSHAW PJM, O'DONNELL DR. Asthma and the common cold: can viruses imitate worms? Thorax 1994: 49: 101-3.
10. ROMAGNANI S. Induction of Th1 and Th2 responses: a key role for the natural immune response. Immunol Today 1992: 13: 379-81.
11. ROUSSET F, GARCIA E, DEFRANCE T, PÉRONNE C, VEZZIO N, HSU D-H ET AL. Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc Natl Acad Sci USA 1992: 89: 1890-3.
12. DEFRANCE T, VANBERVLIET B, BRIÈRE F, DURAND I, ROUSSET F, BANCHEREAU J. Interleukin 10 and transforming growth factor β cooperate to induce anti-CD40-activated naive human B cells to secrete immunoglobulin A. J Exp Med 1992: 175: 671-82.
13. ÖRVELL C, NORRBY E, MUFSON MA. Preparation and characterization of monoclonal antibodies directed against five structural components of human respiratory syncytial virus subgroup B. J Gen Virol 1987: 68: 3125-35.
14. MEURMAN O, RUUSKANEN O, SARKKINEN H, HANNINEN P, HALONEN P. Immunoglobulin class-specific antibody response in respiratory syncytial virus infection measured by enzyme immunoassay. J Med Virol 1984: 14: 67-72.
15. PARROTT RH, KIM HW, ARROBIO JO, HODES DS, MURPHY BR, BRANT CD ET AL. Epidemiology of respiratory syncytial virus infection in Washington, D. C. II. Infection and disease with respect to age, immunologic status, race and sex. Am J Epidemiol 1973: 98: 289-300.
16. HOLBERG CJ, WRIGHT AL, MARTINEZ FD, RAY CG, TAUSSIG LM, LEBOWITZ MD. Risk factors for respiratory syncytial virus-associated lower respiratory illnesses in the first year of life. Am J Epidemiol 1991: 133: 1135-51.
17. COLOCHO-ZELAYA EA, PETTERSSON CA, FORSGREN M, ÖRVELL C, STRANNEGÄRD Ö. Respiratory syncytial virus infection in hospitalized patients and healthy children in El Salvador. Am J Trop Med Hyg 1994: 51: 577-84.
18. COLLINS PL, MCINTOSH K, CHANOCK RM. Respiratory syncytial virus. In Fields Virology, 3rd edition, ed. BN Fields, DM Knipe and PM Howley, Lippincott-Raven publ. Philadelphia-New York, 1995; pp. 1313-51.
19. RICHARDSON LA, YOLKEN RH, BELSHE RB, CARMAGO E, KIM HW, CHANOCK RM. Enzyme linked immunosorbent assay for measurement of serological response to respiratory syncytial virus infection. Infect Immun 1978: 20: 660-4.
20. MURPHY BR, ALLING DW, SNYDER M, WALSH EE, PRINCE GA, CHANOCK RM. Effect of age and preexisting antibody on serum antibody response of infants and children to the F and G glycoproteins during respiratory syncytial viras infection. J Clin Microbiol 1986: 24: 894-8.
21. BUI RH, MOLINAR GA, KETTERING JD, HEINER DC, IMAGAWA DT, ST GEME JN JR. Virus-specific IgE and IgG4 antibodies in serum of children infected with respiratory syncytial virus. J Pediatr 1987: 110: 87-90.
22. TOMS GL, QUINN R, ROBINSON JW. Undetectable IgE responses after respiratory syncytial virus infection. Arch Dis Child 1996: 74: 126-30.
23. MURRAY M, WEBB MSC, O'CALLAGHAN C, SWARBRICK AS, MILNER AD. Respiratory status and allergy after bronchiolitis. Arch Dis Child 1992: 67: 482-7.
24. GAROFALO R, KIMPEN JLL, WELLIVER RC, OGRA PL. Eosinophil degranulation in the respiratory tract during naturally acquired respiratory syncytial virus infection. J Pediatr 1992: 120: 28-32.
25. COLOCHO-ZELAYA EA, ÖRVELL C, STRANNEGÅRD Ö. Eosinophil cationic protein in nasopharyngeal secretions and serum of infants infected with respiratory syncytial virus. Pediatr Allergy Immunol 1994: 5: 100-6.
26. SIGURS N, BJARNASON R, SIGURBERGSSON F. Eosinophil cationic protein in nasal secretion and in serum and myeloperoxidose in serum in respiratory syncytial virus bronchiolitis: relation to asthma and atopy. Acta Pediatr 1994: 83: 1151-5.
27. 4 in bronchiolitis due to respiratory syncytial virus. Pediatr Allergy Immunol 1991: 2: 30-7.
28. SANCHEZ-LEGRAND F, SMITH TF. Interaction of paramyxoviruses with human basophils and their effect on histamine release. J Allergy Clin Immunol 1989: 84: 538-46.
29. MARTINEZ FD, MORGAN WJ, WRIGHT AL, HOLBERG CJ, TAUSSIG LM. Diminished lung function as a predisposing factor for wheezing respiratory illness in infants. N Eng J Med 1988: 391: 1112-17.
30. MARTINEZ FD, MORGAN WJ, WRIGHT AL, HOLBERG CJ, TAUSSIG LM. Initial airway function is a risk factor for recurrent wheezing respiratory illnesses during the first three years of life. Am Rev Respir Dis 1991: 143: 312-6.